News

Cancer drug neratinib offers hope for type 1 diabetes treatment

A drug used to treat breast cancer, neratinib, has the potential to halt the immune system from destroying beta cells in type 1 diabetes, according to German researchers. Neratinib was able to guard the beta cells, which produce insulin in the pancreas, from attack. The JDRF-funded study showed that the treatment enabled the beta cells […]

News

US companies celebrate 25-year commitment to curing type 1 diabetes

A 25-year relationship between two companies committed to curing type 1 diabetes is being celebrated through Diabetes Awareness Month. In 1994, the Diabetes Research Institute (DRI) teamed up with Biorep Technologies Inc, a Miami-based company that manufactures critical research equipment. The partnership began when Biorep founder Ramon Poo became involved with the DRI after his […]

News

UCSD team receives $9 million grant for diabetes research

SAN DIEGO — UC San Diego announced Tuesday it received roughly $9 million in grants for a pair of research projects that will attempt to identify the cellular actions that lead to the development of Type 1 Diabetes. The National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, […]

News

Happy Mother’s Day!

Happy Mother’s day to all the moms out there! I know I personally couldn’t have done this without my mom! Our contest ends in 3 hours! Make sure you enter! We want you to win a tumbler for you or your mom! It’s gonna get there late, but that’s just a way to extend the […]

News

Groundbreaking results in type 1 diabetes research

Story by Christiane Manow-Le Ruyet | Nov 29, 2018 | Tags: Helmholz Zentrum, muenchen, stemm cells MUNICH, 29th November 2018 – German scientists have taken a major step forward in research into type 1 diabetes. They have identified the signals responsible for the development of immature pancreatic cells. This could pave the way for the modification […]